애브비 (ABBV)

전일 마감가:

$160.81

열려 있는:

$161.16

하루 거래량:

5.53M

시가총액:

$290.01B

수익:

$54.40B

순이익/손실:

$5.99B

주가수익비율:

44.87

EPS:

3.65

순현금흐름:

$22.06B

1주 성능:

+2.61%

1개월 성능:

-7.64%

6개월 성능:

+15.82%

1년 성능:

+9.74%

1일 변동 폭

$160.74

$164.25

52주 변동 폭

$130.96

$182.89

애브비 Stock (ABBV) Company Profile

명칭

Abbvie Inc

부문

Healthcare (1213)

산업

Drug Manufacturers - General (18)

전화

847-932-7900

주소

1 North Waukegan Road, North Chicago, IL

직원

30,000

트위터

@abbvie

다음 수익 날짜

2024-05-03

최신 SEC 제출 서류

ABBV's Discussions on Twitter

애브비 Stock (ABBV) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2024-01-29	업그레이드	William Blair	Mkt Perform → Outperform
2023-12-18	다운그레이드	HSBC Securities	Buy → Hold
2023-12-11	업그레이드	Goldman	Neutral → Buy
2023-11-09	개시	Deutsche Bank	Hold
2023-10-30	업그레이드	Barclays	Equal Weight → Overweight
2023-10-20	재개	UBS	Neutral
2023-09-29	개시	Raymond James	Outperform
2023-07-25	개시	William Blair	Mkt Perform
2023-07-14	개시	HSBC Securities	Buy
2023-04-05	다운그레이드	Argus	Buy → Hold
2023-03-01	개시	Guggenheim	Buy
2023-02-22	다운그레이드	Wolfe Research	Outperform → Peer Perform
2023-02-10	업그레이드	SVB Securities	Underperform → Market Perform
2022-11-18	개시	Credit Suisse	Outperform
2022-11-08	다운그레이드	Societe Generale	Buy → Hold
2022-08-01	다운그레이드	Atlantic Equities	Overweight → Neutral
2022-05-23	개시	SVB Leerink	Underperform
2022-05-06	다운그레이드	Daiwa Securities	Outperform → Neutral
2022-04-06	재개	Morgan Stanley	Overweight
2022-02-28	다운그레이드	UBS	Buy → Neutral
2022-02-03	재확인	BMO Capital Markets	Outperform
2022-02-03	재확인	Barclays	Equal Weight
2022-02-03	재확인	BofA Securities	Neutral
2022-02-03	재확인	Goldman	Neutral
2022-01-13	개시	Redburn	Buy
2022-01-12	재확인	BMO Capital Markets	Outperform
2021-12-09	재개	Wells Fargo	Overweight
2021-11-23	업그레이드	Societe Generale	Hold → Buy
2021-07-27	재개	Truist	Buy
2021-04-07	재개	RBC Capital Mkts	Outperform
2020-11-10	재개	Bernstein	Outperform
2020-09-29	개시	Berenberg	Hold
2020-06-23	업그레이드	Atlantic Equities	Neutral → Overweight
2020-06-09	업그레이드	Wolfe Research	Peer Perform → Outperform
2020-06-02	업그레이드	Argus	Hold → Buy
2020-05-18	재개	BofA/Merrill	Neutral
2020-05-12	업그레이드	JP Morgan	Neutral → Overweight
2020-05-11	재개	Morgan Stanley	Overweight
2020-04-20	업그레이드	RBC Capital Mkts	Sector Perform → Outperform
2020-03-23	다운그레이드	Societe Generale	Buy → Hold
2020-02-27	개시	Barclays	Equal Weight
2020-02-06	개시	Mizuho	Buy
2020-01-07	개시	RBC Capital Mkts	Sector Perform
2019-12-26	재확인	Cowen	Outperform
2019-09-26	업그레이드	Citigroup	Neutral → Buy
2019-08-20	업그레이드	Piper Jaffray	Neutral → Overweight
2019-06-27	업그레이드	Wolfe Research	Underperform → Peer Perform
2019-06-26	업그레이드	SVB Leerink	Mkt Perform → Outperform
2019-05-28	개시	Goldman	Neutral
2019-04-29	업그레이드	BMO Capital Markets	Underperform → Market Perform

모두보기

애브비 주식(ABBV)의 최신 뉴스

Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims

Zacks Investment Research

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks Investment Research

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock

Zacks Investment Research

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Zacks Investment Research

Is WisdomTree U.S. Quality Dividend Growth ETF (DGRW) a Strong ETF Right Now?

Zacks Investment Research

AbbVie (ABBV) Could Be a Great Choice

Zacks Investment Research

애브비 (ABBV) 재무 분석

애브비 (ABBV) 매출 2024

애브비 (ABBV) 순이익 2024

애브비 (ABBV) 현금흐름 2024

애브비 (ABBV) 주당 순이익 2024